Single-cell RNA-seq profiles of tumor-bearing mice treated with PAGln with or without anti-PD-1

single-cell RNA sequencing (scRNA-seq) profiles of tumor-bearing mice treated using Phenylacetylglutamine (PAGln) with or without anti-PD-1 were performed to compare the alterations of immune microenvironment affected by PAGln under the condition of anti-PD-1 treatment.